Glipizide and Ocaliva drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Glipizide (glipizide) and Ocaliva (obeticholic acid). Common drug interactions include alopecia among females and hospitalisation among males.

The phase IV clinical study analyzes what interactions people have when they take Glipizide and Ocaliva. It is created by eHealthMe based on reports of 65 people who take the same drugs from the FDA, and is updated regularly.

What is Glipizide?

Glipizide has active ingredients of glipizide. It is often used in diabetes. eHealthMe is studying from 64,852 Glipizide users. Check the latest studies of Glipizide.

What is Ocaliva?

Ocaliva has active ingredients of obeticholic acid. eHealthMe is studying from 6,919 Ocaliva users. Check the latest studies of Ocaliva.



On Jul, 12, 2026

65 people who take Glipizide and Ocaliva together, and have interactions are studied.

Glipizide and Ocaliva drug interactions.

What are the common drug interactions of Glipizide and Ocaliva, by gender? *:

female:

  1. Alopecia (absence of hair from areas of the body)
  2. Nausea (feeling of having an urge to vomit)
  3. Constipation
  4. Fatigue (feeling of tiredness)
  5. Hepatic enzyme increased
  6. Cough
  7. Death
  8. Nasopharyngitis (inflammation of the nasopharynx)
  9. Pain
  10. Pyrexia (fever)

male:

  1. Hospitalisation
  2. Pruritus (severe itching of the skin)
  3. Death
  4. Musculoskeletal disorder (disease of the body's muscles, joints, tendons, ligaments and nerves)
  5. Abdominal discomfort
  6. Chills (felling of cold)
  7. Disease progression
  8. Dizziness
  9. International normalised ratio increased

What are the common drug interactions of Glipizide and Ocaliva, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Pruritus (severe itching of the skin)
  2. Musculoskeletal disorder (disease of the body's muscles, joints, tendons, ligaments and nerves)
  3. Abdominal discomfort
  4. Chills (felling of cold)
  5. Dizziness
  6. Hospitalisation
  7. International normalised ratio increased
  8. Liver disorder (liver diseases)
  9. Pulmonary oedema (fluid accumulation in the lungs)
  10. Surgery

60+:

  1. Pruritus (severe itching of the skin)
  2. Death
  3. Alopecia (absence of hair from areas of the body)
  4. Diarrhoea
  5. Disease progression
  6. Hip fracture
  7. Memory impairment
  8. Post procedural infection
  9. Pruritus generalised (generalized itching)
  10. Rash pruritic (redness with itching)

What are the existing conditions these people have? *

  1. Biliary Cirrhosis Primary (primary biliary cirrhosis (pbc) is a long-term liver disease that damages the small bile ducts in the liver. the build-up of bile damages the liver): 13 people, 20.00%
  2. Biliary Cirrhosis (biliary cirrhosis occurs due to obstruction to the flow of bile through bile ducts either within the liver or outside the liver): 6 people, 9.23%

* Approximation only. Some reports may have incomplete information.

Do you take Glipizide and Ocaliva?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Glipizide and Ocaliva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Glipizide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ocaliva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Glipizide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ocaliva and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on glipizide and obeticholic acid (the active ingredients of Glipizide and Ocaliva, respectively), and Glipizide and Ocaliva (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: